Form 8-K - Current report:
SEC Accession No. 0001493152-21-022044
Filing Date
2021-09-03
Accepted
2021-09-03 17:26:10
Documents
12
Period of Report
2021-09-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44246
  Complete submission text file 0001493152-21-022044.txt   221266

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT envb-20210902.xsd EX-101.SCH 3021
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT envb-20210902_lab.xml EX-101.LAB 34239
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT envb-20210902_pre.xml EX-101.PRE 22356
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3721
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 211237538
SIC: 2834 Pharmaceutical Preparations